The MiniMed™ 770G insulin pump system automatically* adjusts background insulin every 5 minutes. Using real-time sugar readings, the system calculates a personalized amount of insulin to deliver based on your needs.
The system connects directly with a smart device, allowing you to view sugar trends and insulin data on the go!
The MiniMed™ 630G system uses SmartGuard™ technology and lets you know up to 30 minutes ahead if you’re trending high or low, so you can act sooner to keep your glucose levels where you want them.
The optional CGM sends information to your pump every five minutes, so you can see how you’re doing, spot trends and make adjustments!
The amount you will pay with Flex is calculated by dividing your total out-of-pocket responsibility by 48 and adding the $6 service fee.
Your total coinsurance amount is dependent on your insurance coverage.
WHAT IS INCLUDED WITH FLEX?
Flex payments cover your out-of-pocket cost for a Medtronic insulin pump and starter kit. The starter kit includes transmitter and a 3-month supply of the following items: sensors, infusion sets, and reservoirs.
Flex payments do not include ongoing supplies beyond (or after) the first 90 days. To continue using pump therapy, you must purchase additional transmitters, sensors, infusion sets, and reservoirs separately.
Get Started.
Call us at 800-646-4633 Option 3 between the hours of 9AM - 6PM CST or complete the form to receive a call from us.
Any customers purchasing a pump using most commercial insurance plans after 1/2/19 are eligible. You can learn more about the program terms at www.medtronicdiabetes.com/flex.
The 48-month payment plan is our standard option. You may choose to pay off the balance faster with any other term, such as 24 months but not to exceed 48 months.
The program offering estimated the monthly cost for most patients. The "around $49/month" refers to average out of pocket costs over 48 months. Because insurance coverage and payment plan length varies, the individual amount may be higher or lower.
You’ll be responsible for paying the coinsurance amount that is required at the time of purchase. If you change insurance during your pump warranty period, you’ll still be responsible for making the same payment amount.
Within 30 days of your pump shipping, you will receive a welcome notification from Monterey Financial Services (MFS), which will include details on how to make your monthly Flex payments.
No credit check is required to start the payment plan.
References
* $49/month estimate is calculated based on average out-of-pocket cost paid over 48 months. Monthly payments include a $6/month service fee. Final cost may be higher or lower than $49/month depending on individual insurance.
§ Refers to Auto Mode. Individual results may vary. Some interaction required.
Program Terms
$49/month estimate is calculated based on average out-of-pocket cost paid over 48 months.
Monthly payments include a $6/month service fee.
Final cost may be higher or lower than $49/month depending on individual insurance.
Patient may elect to pay a portion or all of the upfront cost at any time, without penalty.
Starter kit includes one (1) transmitter and a 90-day supply of sensors, infusion sets, and reservoirs associated with your insulin pump.
Monthly payments for Flex do not include ongoing supplies except for the first 90 days. To continue using pump therapy, patients must purchase additional transmitters, sensors, infusion sets, and reservoirs separately.
No upfront payment is required and first month payment will begin 30-60 days after pump shipment. Individual payment timelines may vary.
MiniMed™ pumps have certain labeling restrictions that may exclude certain populations, including age and type of diabetes. We recommend you consult your healthcare provider.
A valid prescription will be required to purchase. Other restrictions may apply.
Program terms are subject to change at any time and without notice.
BACK TO HOW FLEX WORKS Important Safety Information: MiniMed™ 770G System With SmartGuard™ Technology
The MiniMed™ 770G system is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of type 1 diabetes mellitus in persons two years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed™ 770G System includes SmartGuard™ technology, which can be programmed to automatically adjust delivery of basal insulin based on continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values. The Medtronic MiniMed™ 770G System consists of the following devices: MiniMed™ 770G Insulin Pump, the Guardian™ Link (3) Transmitter, the Guardian™ Sensor (3), one-press serter, the Accu-Chek® Guide Link blood glucose meter, and the Accu-Chek® Guide Test Strips. The system requires a prescription.The Guardian™ Sensor (3) has not been evaluated and is not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required. All therapy adjustments should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian™ Sensor (3).
All therapy adjustments should be based on measurements obtained using the Accu-Chek® Guide Link blood glucose meter and not on values provided by the Guardian™ Sensor (3). Always check the pump display to ensure the glucose result shown agrees with the glucose results shown on the Accu-Chek® Guide Link blood glucose meter. Do not calibrate your CGM device or calculate a bolus using a blood glucose meter result taken from an Alternative Site. It is not recommended to calibrate your CGM device when sensor or blood glucose values are changing rapidly, e.g., following a meal or physical exercise.
WARNING: Do not use the SmartGuard™ Auto Mode for people who require less than eight units or more than 250 units of total daily insulin per day. A total daily dose of at least eight units, but no more than 250 units, is required to operate in SmartGuard™ Auto Mode.
WARNING: Do not use the MiniMed™ 770G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed™ 770G system.
Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional. The safety of the MiniMed™ 770G system has not been studied in pregnant women. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult https://www.medtronicdiabetes.com/important-safety-information#minimed-770g and the appropriate user guide at http://www.medtronicdiabetes.com/download-library
Important Safety Information: MiniMed™ 630G System with SmartGuard™ Technology
Indicated for the continuous delivery of insulin, at set and variable rates, for the management of diabetes mellitus. MiniMed™ 630G system is approved for ages 14 years or older with Guardian™ Sensor 3 and MiniMed™ 630G system is approved for ages 16 years or older with Enlite™ sensor. Both systems require a prescription. Insulin infusion pumps and associated components of insulin infusion systems are limited to sale by or on the order of a physician and should only be used under the direction of a healthcare professional familiar with the risks of insulin pump therapy. Pump therapy is not recommended for people who are unwilling or unable to perform a minimum of four blood glucose tests per day. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional. Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Insulin pumps use rapid-acting insulin. If your insulin delivery is interrupted for any reason, you must be prepared to replace the missed insulin immediately. Replace the infusion set every 48–72 hours, or more frequently per your healthcare professional’s instructions. Insertion of a glucose sensor may cause bleeding or irritation at the insertion site. Consult a physician immediately if you experience significant pain or if you suspect that the site is infected. The information provided by CGM systems is intended to supplement, not replace, blood glucose information obtained using a blood glucose meter. A confirmatory fingerstick using a CONTOUR®NEXT LINK 2.4 meter is required prior to making adjustments to diabetes therapy. Always check the pump display when using a CONTOUR®NEXT LINK 2.4 meter, to ensure the glucose result shown agrees with the glucose results shown on the meter. Do not calibrate your CGM device or calculate a bolus using a result taken from an Alternative Site (palm) or a result from a control solution test. If a control solution test is out of range, please note that the result may be transmitted to your pump when in the “Always” send mode. It is not recommended to calibrate your CGM device when sensor or blood glucose values are changing rapidly, e.g., following a meal or physical exercise. The MiniMed™ 630G system is not intended to be used directly for preventing or treating hypoglycemia but to suspend insulin delivery when the user is unable to respond to the Suspend on low alarm and take measures to prevent or treat hypoglycemia themselves. Therapy to prevent or treat hypoglycemia should be administered according to the recommendations of the user’s healthcare provider.
WARNING: The SmartGuard™ Suspend on low feature will cause the pump to temporarily suspend insulin delivery for two hours when the sensor glucose reaches a set threshold. Under some conditions of use the pump can suspend again, resulting in very limited insulin delivery. Prolonged suspension can increase the risk of serious hyperglycemia, ketosis, and ketoacidosis. Before using the SmartGuard™ feature, it is important to read the SmartGuard™ feature information in the User Guide and discuss proper use of the feature with your healthcare provider.
Insertion of a glucose sensor may cause bleeding or irritation at the insertion site. Consult a physician immediately if you experience significant pain or if you suspect that the site is infected. Please visit important safety information for more details.
The CONTOUR®NEXT LINK 2.4 Meter is used with the MiniMed™ 630G system.
940M20191-013 04APR2019
Ascensia, the Ascensia Diabetes Care logo, and Contour are trademarks and/or registered trademarks of Ascensia Diabetes Care.
AT
AU
BE
CA
CH
CN
CZ
DE
DK
ES
FI
FR
GR
HU
IE
IN
IT
JP
NL
NO
PL
PT
RU
SE
UK
ZA
Menu
Alert: Product and Safety Notice
